Cell-Based Therapies Show Promise for Seriously Ill Patients with COVID-19: Federal Funding for Large-Scale, Randomized, Controlled Trials is Needed to Confirm Results and Help Bring Safe and Effective Treatments to Patients in Need

Cell-Based Therapies Show Promise for Seriously Ill Patients with COVID-19: Federal Funding for Large-Scale, Randomized, Controlled Trials is Needed to Confirm Results and Help Bring Safe and Effective Treatments to Patients in Need

Washington, DC (March 24, 2021) – A new report released by Alliance for Cell Therapy Now, an independent, non-profit organization guided by leaders representing academic and medical institutions, industry innovators, and patients, summarizes clinical studies that are...

Alliance for Cell Therapy Now Commends Congress for Regenerative Medicine and Cell Therapy Provisions in FY 2021 Spending Bill: Additional Support for Clinical Trials for COVID Patients is Still Needed

Washington, DC (December 30, 2020) – Leaders of Alliance for Cell Therapy Now (ACT Now)—including representatives of academic and medical institutions, industry innovators, and patients—applaud Congress for its inclusion of important provisions in the final FY 2021...